Premarket Gainer
DARE Dare Bioscience2.12+0.20+10.5%
Premarket:2.93+0.81 (+38.1%)
Dar Announces FDA Approval of XACIATO (clindamycin phosphate) Vaginal Gel as a Treatment for Bacterial Vaginosis
Globe NewswireTue, 7-Dec 4:15 PM
DARE Dare Bioscience Inc.0.840.00-0.3%
Premarket:2.15+1.31 (+156.6%)
Bayer and Dar Bioscience Announce Exclusive Licensing Agreement for U.S. Commercial Rights to Ovaprene , an Investigational Hormone-Free, Monthly Contraceptive
Business WireMon, 13-Jan 7:00 AM
DARE Dare Bioscience Inc.0.92+0.03+3.7%
Premarket:2.17+1.25 (+135.9%)
Dar Bioscience, Inc. to Present at the 31st Annual ROTH Conference
Globe NewswireMon, 18-Mar 8:31 AM
DARE Dare Bioscience Inc.0.85-0.02-2.2%
Premarket:1.36+0.51 (+59.8%)
Dar Bioscience, Inc. Announces Licensing and Global Rights to Novel Phase III Product Candidate for the Treatment of Bacterial Vaginosis
Globe NewswireThu, 6-Dec 8:01 AM
